JP2009538852A5 - - Google Patents

Download PDF

Info

Publication number
JP2009538852A5
JP2009538852A5 JP2009512481A JP2009512481A JP2009538852A5 JP 2009538852 A5 JP2009538852 A5 JP 2009538852A5 JP 2009512481 A JP2009512481 A JP 2009512481A JP 2009512481 A JP2009512481 A JP 2009512481A JP 2009538852 A5 JP2009538852 A5 JP 2009538852A5
Authority
JP
Japan
Prior art keywords
alkyl
methyl
pyrido
imidazo
pyrazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009512481A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009538852A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/004747 external-priority patent/WO2007137819A1/en
Publication of JP2009538852A publication Critical patent/JP2009538852A/ja
Publication of JP2009538852A5 publication Critical patent/JP2009538852A5/ja
Pending legal-status Critical Current

Links

JP2009512481A 2006-05-30 2007-05-29 4−アミノ−ピリド[3,2−e]ピラジン、該化合物のホスホジエステラーゼ10の阻害剤としての使用、及び該化合物の製造方法 Pending JP2009538852A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80925106P 2006-05-30 2006-05-30
PCT/EP2007/004747 WO2007137819A1 (en) 2006-05-30 2007-05-29 4-AMINO-PYRIDO[3,2-e]PYRAZINES, THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE 10, AND PROCESSES FOR PREPARING THEM

Publications (2)

Publication Number Publication Date
JP2009538852A JP2009538852A (ja) 2009-11-12
JP2009538852A5 true JP2009538852A5 (https=) 2010-07-15

Family

ID=38441601

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009512481A Pending JP2009538852A (ja) 2006-05-30 2007-05-29 4−アミノ−ピリド[3,2−e]ピラジン、該化合物のホスホジエステラーゼ10の阻害剤としての使用、及び該化合物の製造方法

Country Status (13)

Country Link
US (1) US20070299079A1 (https=)
EP (1) EP2021341A1 (https=)
JP (1) JP2009538852A (https=)
CN (1) CN101448829A (https=)
AR (1) AR060984A1 (https=)
AU (1) AU2007267391A1 (https=)
BR (1) BRPI0711857A2 (https=)
CA (1) CA2653412A1 (https=)
CL (1) CL2007001555A1 (https=)
MX (1) MX2008015308A (https=)
PE (1) PE20080266A1 (https=)
TW (1) TW200815436A (https=)
WO (1) WO2007137819A1 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8299080B2 (en) 2006-12-13 2012-10-30 Aska Pharmaceutical Co., Ltd. Substituted imidazo[1,5-A] quinoxalines as a PDE9 inhibitor
KR20100110804A (ko) * 2007-11-30 2010-10-13 와이어쓰 엘엘씨 포스포디에스테라제 10의 저해물질로서의 아릴 및 헤테로아릴 융합된 이미다조[1,5-a]피라진
US20090143361A1 (en) * 2007-11-30 2009-06-04 Elbion Gmbh Pyrido[3,2-E]Pyrazines, Process For Preparing The Same, And Their Use As Inhibitors Of Phosphodiesterase 10
US20090143392A1 (en) * 2007-11-30 2009-06-04 Elbion Gmbh Methods of Treating Obesity and Metabolic Disorders
WO2010054260A1 (en) * 2008-11-07 2010-05-14 Biotie Therapies Gmbh Imidazo[5,1-c][1,2,4]benzotriazine derivatives as inhibitors of phosphodiesterases
US8969349B2 (en) * 2010-05-26 2015-03-03 Sunovion Pharmaceuticals Inc. Substituted quinoxalines and quinoxalinones as PDE-10 inhibitors
DE102010042833B4 (de) 2010-10-22 2018-11-08 Helmholtz-Zentrum Dresden - Rossendorf E.V. Neue Halogenalkoxychinazoline, deren Herstellung und Verwendung
US9540379B2 (en) 2011-01-31 2017-01-10 Boehringer Ingelheim International Gmbh (1,2,4)triazolo[4,3-A]quinoxaline derivatives as inhibitors of phosphodiesterases
CA2827724A1 (en) 2011-02-18 2012-08-23 Allergan, Inc. Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
US9938269B2 (en) 2011-06-30 2018-04-10 Abbvie Inc. Inhibitor compounds of phosphodiesterase type 10A
EP2763989A1 (en) * 2011-09-09 2014-08-13 H. Lundbeck A/S Pyridine compounds and uses thereof
BR112015007731B1 (pt) 2011-10-10 2022-05-31 H. Lundbeck A/S Composto, composição farmacêutica que o compreende e uso do mesmo
SG11201402134VA (en) 2011-11-09 2014-06-27 Abbvie Deutschland Heterocyclic carboxamides useful as inhibitors of phosphodiesterase type 10a
US20130116241A1 (en) 2011-11-09 2013-05-09 Abbvie Inc. Novel inhibitor compounds of phosphodiesterase type 10a
BR112014018199A8 (pt) 2012-01-26 2021-03-02 H Lundbeck As inibidores da pde9 com cadeia principal imidazo triazinona, composição farmacêutica que os compreende, uso dos referidos inibidores e processo para sua preparação
NZ631258A (en) 2012-04-25 2016-11-25 Takeda Pharmaceuticals Co Nitrogenated heterocyclic compound
EP2861596B1 (en) 2012-06-19 2019-03-20 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
WO2014010732A1 (ja) 2012-07-13 2014-01-16 武田薬品工業株式会社 複素環化合物
US20140045856A1 (en) * 2012-07-31 2014-02-13 Boehringer Ingelheim International Gmbh 4-Methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes
US9464085B2 (en) * 2012-08-17 2016-10-11 AbbVie Deutschland GmbH & Co. KG Inhibitor compounds of phosphodiesterase type 10A
WO2014041175A1 (en) 2012-09-17 2014-03-20 Abbott Gmbh & Co. Kg Novel inhibitor compounds of phosphodiesterase type 10a
WO2014071044A1 (en) 2012-11-01 2014-05-08 Allergan, Inc. Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a)
US9790203B2 (en) 2012-11-26 2017-10-17 Abbvie Inc. Inhibitor compounds of phosphodiesterase type 10A
US9200005B2 (en) 2013-03-13 2015-12-01 AbbVie Deutschland GmbH & Co. KG Inhibitor compounds of phosphodiesterase type 10A
EP2970258B1 (en) 2013-03-14 2018-04-18 AbbVie Deutschland GmbH & Co KG Novel inhibitor compounds of phosphodiesterase type 10a
EP2975031A4 (en) 2013-03-14 2017-04-19 Takeda Pharmaceutical Company Limited Heterocyclic compound
JP6427491B2 (ja) 2013-07-03 2018-11-21 武田薬品工業株式会社 複素環化合物
EP3018123B1 (en) 2013-07-03 2023-05-10 Takeda Pharmaceutical Company Limited Amide compound
US9200016B2 (en) 2013-12-05 2015-12-01 Allergan, Inc. Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
CN103980281B (zh) * 2014-05-27 2016-06-08 天津市斯芬克司药物研发有限公司 一种咪唑吡嗪化合物及其制备方法
PT3865484T (pt) 2015-07-07 2024-01-30 H Lundbeck As Inibidor da pde9 com esqueleto de imidazo pirazinona para tratamento de doenças periféricas
CA3100988A1 (en) 2018-05-25 2019-11-28 Imara Inc. Monohydrate and crystalline forms of 6-[(3s,4s)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7h-imidazo[1,5-a]pyrazin-8-one
CA3110680A1 (en) 2018-08-31 2020-03-05 Imara Inc. Pde9 inhibitors for treating sickle cell disease
EP3856185A1 (en) 2018-09-28 2021-08-04 Takeda Pharmaceutical Company Limited Balipodect for treating or preventing autism spectrum disorders
CN114524808B (zh) * 2022-02-21 2023-10-24 深圳市儿童医院 一种吡唑衍生物及其作为pde10抑制剂的用途
CN114524806B (zh) * 2022-02-22 2024-09-03 深圳市儿童医院 一种三氮唑衍生物及其作为pde10抑制剂的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2322311C (en) * 1998-03-04 2009-10-13 Bristol-Myers Squibb Company Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors
JPH11292878A (ja) * 1998-04-09 1999-10-26 Yamanouchi Pharmaceut Co Ltd イミダゾナフチリジン誘導体
US20030032579A1 (en) * 2001-04-20 2003-02-13 Pfizer Inc. Therapeutic use of selective PDE10 inhibitors
IL149106A0 (en) * 2001-04-20 2002-11-10 Pfizer Prod Inc Therapeutic use of selective pde10 inhibitors
TW200817400A (en) * 2006-05-30 2008-04-16 Elbion Ag Pyrido [3,2-e] pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them

Similar Documents

Publication Publication Date Title
JP2009538852A5 (https=)
EP3317289B1 (en) Novel substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection
JP6236173B2 (ja) 脊髄性筋萎縮症を処置するための化合物
AU2016256728B2 (en) Thiadiazole analogs thereof and methods for treating smn-deficiency-related-conditions
US7550465B2 (en) Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
JP5820921B2 (ja) 1,2−二置換複素環式化合物
CN101678014B (zh) 杂环激酶调节剂
CA2866143C (en) Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use
JP6600319B2 (ja) ヒストンデアセチラーゼ阻害薬及び組成物並びにそれらの使用の方法
CN115448910A (zh) 一种哒嗪类衍生物抑制剂、其制备方法和应用
JP2009538853A5 (https=)
US20070299079A1 (en) 4-AMINO-PYRIDO[3,2-e]PYRAZINES, THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE 10, AND PROCESSES FOR PREPARING THEM
CN106008479B (zh) 作为磷脂酰肌醇3-激酶δ抑制剂的取代嘧啶类化合物及其应用
CN102164604A (zh) 用作激酶调节剂的稠合杂环化合物
AU2013355054B2 (en) Diazole lactams
CN108137539B (zh) 取代的苯并咪唑、它们的制备和它们作为药物的用途
JP2020532585A (ja) インターフェロン遺伝子刺激因子調節薬としての環状ジヌクレオチド
CN105936635B (zh) 作为磷脂酰肌醇3-激酶δ抑制剂的化合物及其应用
RS63581B1 (sr) Inhibitori p38 kinaze smanjuju ekspresiju dux4 i nizvodnih gena u cilju lečenja fshd
AU2011258005A1 (en) Heterocyclic compounds as Janus kinase inhibitors
RS52838B (sr) Fenoksimetil heterociklična jedinjenja
CN106414459B (zh) 作为pde1抑制剂的六氢呋喃并吡咯
JP2021506852A (ja) Hbv感染と関連する疾患を治療するためのイソキサゾール化合物
CN112592345B (zh) 一种三氮唑并吡嗪类化合物及其用途
TW201215607A (en) Aryl-and heteroarylamid derivatives as PDE10A enzyme inhibitor